Cardiac Rhythm Management
Articles Articles 2011 December

Advances in Imaging to Assist Atrial Fibrillation Ablation


Steward St. Elizabeth Medical Center, Tufts University Medical School, Boston, MA

PDF Download PDF


ABSTRACT. Catheter ablation procedures to treat atrial fibrillation require sophisticated imaging for guidance. These imaging techniques have evolved from basic two-dimensional to complex three-dimensional methods that may involve fusion of data from different modalities such as computed tomography, magnetic resonance imaging, fluoroscopy, echocardiography and electroanatomical mapping. Summation of errors inherent with each individual tool can be a problem and new methods are under development. A quest for more user-friendly and highly accurate imaging tools continues.

KEYWORDS. Cardiac Imaging, Atrial Fibrillation, Catheter Ablation, Transesophageal Echocardiography, Intracardiac Imaging Techniques, Computed X Ray Tomography, Magnetic Resonance Imaging, Imaging, Three-Dimensional, Image Reconstruction, Left atrium, Pulmonary vein, Electrophysiology.


Michael Orlov has received research grants and consulting from Philips Healthcare and C.R. Bard Electrophysiology.
Manuscript received October 30, final version accepted November 14, 2011.

Address correspondence to: Michael V. Orlov, MD, PhD, Director of Arrhythmia Service, Steward St. Elizabeth Medical Center, Associate Professor of Medicine, Tufts University Medical School, 736 Cambridge St, Boston, MA 02135. E-mail:


Catheter ablation procedure for atrial fibrillation (AF) is becoming the mainstay of therapy for several forms of this arrhythmia and, consequently, more widely available. Technique of pulmonary vein (PV) focal ablation described initially1 has undergone multiple modifications and in its current form has become virtually impossible without the assistance of complex imaging. Multiple imaging methods have been utilized to guide AF ablation. Their development has led to the appearance of fairly complex and expensive technology that frequently involves a combination of several imaging modalities. As a result of this growth, several trends can be observed. One trend is the spread of AF catheter ablation procedures from academic to community hospitals. This ubiquity has brought about a parallel need for more standardized and simplified procedural approaches as healthcare institutions economize the expense and inefficiency of standalone imaging methods. In this review, we will focus on the development of modern imaging technologies to guide AF ablation and compare them in order to provide a comprehensive approach to the “choice of arms”.

Imaging modalities to assist atrial fibrillation ablation


Historically, fluoroscopy has been the primary imaging modality to facilitate electrophysiological procedures. When combined with sophisticated mapping catheters,2 fluoroscopy alone can provide a imaging guide for AF ablation. The main advantages of this modality are availability, simplicity of use, low cost, and technical familiarity for all operators. However, the complexity of left atrial anatomy, frequent anomalies, and the presence of intricate arrhythmia mechanisms led most electrophysiologists to embrace some form of three-dimensional (3D) imaging for their ablation protocols. Additionally, due to its inherent radiation risk, there is a trend to limit fluoroscopy use. Recently, the feasibility of “fluoroless” AF ablation has been described.3,4

Cardiac computed tomography and magnetic resonance imaging

Three- reconstruction of cardiac structures from cardiac computed tomography (CT) revolutionized understanding of left atrial anatomy and greatly facilitated the development of AF ablation (Figure 1). Detailed characterization of anatomic variants included a description of commonly observed two right and two left-sided PVs, their size and shape, and less often encountered variants, e.g. accessory right sided PVs, single right ostium PV and single left ostium PV.5 Sizing and location information provided by 3D imaging may become even more important with the advent of complex ablation tools such as cryoballoons. “One size does not fit all” and therefore pre-procedural determination of the tool size becomes more critical. The anatomical interrelationship of extracardiac structures (esophagus, phrenic nerve, etc.) to the left atrium (LA) and PVs is important in view of their vulnerability to ablative injury.6 Through CT, we have learned about different esophageal locations (common and uncommon), and their proximity to the LA.7–10


Figure 1: (a) Cardiac computed tomography (CT); (b) segmental cuts; (c) cardiac CT three-dimensional rendered; (d) segmented left atrium and esophagus as seen in angulated posterior views. Green arrows point to measurements of pulmonary vein diameters. The esophagus is shown in brown.

Similarly, cardiac magnetic resonance imaging (MRI) can provide detailed information about variations of LA and PV anatomy.11 Interesting findings have come from detailed characterization of LA fibrosis by delayed enhanced imaging.12 Recently proposed Utah staging that attempts to categorize the extent of fibrosis seems to correlate with epidemiological variables and AF ablation outcomes (Figure 2).13 Delayed-enhancement MRI can show incomplete circumferential scar lesions after AF ablation and may be used to target those breaks during repeat ablation.14 Additionally, the same group has demonstrated that MRI can be used to guide catheter navigation while directly visualizing ablation lesions during RF (radiofrequency) energy delivery.15 However, at approximately 20% of Carto-tagged ablation sites there was no visible corresponding scar by delayed enhancement as shown by another prominent imaging group.16


Figure 2: A series of left atrial magnetic resonance imaging three-dimensional reconstructions displayed in the right anterior oblique and posterior-anterior projections illustrating areas of fibrosis (bright green) across the four stages of fibrosis. Utah stage 1: 35% fibrosis.13

Respiratory changes in PV and LA location are important and may affect the ablation approach.17 Fortunately, relative motion of PV centers is fairly small (2.6±1.4 mm) when compared with more distal PVs and the mitral annulus; this knowledge is important when selecting the appropriate tool for merging radiographic images into a 3D replica of the LA. Finally, overlay of a 3D shell of the LA on live fluoroscopy has been introduced as one of the first merge techniques to provide detailed anatomical views intraprocedurally.18,19 Close correspondence (1.3±0.6 mm) of these reconstructed and registered LA images with actual anatomy confirmed by catheter mapping has been reported.19 Respiratory motion of the LA and PVs remains important for registration of a 3D shell on live fluoroscopy. Several current versions of imaging software incorporate some form of compensation for respiratory motion.

The disadvantages of CT and MRI include the need for expensive scanners and usually coordination between two different departments. As a consequence, CT/MRI is typically performed several days before the ablation procedure and may reflect a different volume/anatomical status. Additionally, surrounding organs depicted by CT such as the esophagus may be in a different position and their CT representation may not be accurate.20 Also, radiation exposure from a CT scan is not negligible despite recent advances in dose reduction techniques, particularly when combined with the subsequent fluoroscopy dose from AF ablation.21–23 Patient safety is yet another consideration with contrast associated with cardiac CT.

MRI obviates the risks of radiation exposure, especially benefiting younger patients and those who undergo multiple imaging procedures. However, MRI-guided electrophysiology (EP) procedures are currently cost prohibitive, require expertise, and the technology that may not be widely available, particularly in community hospitals. Several contraindications to MRI exist. Implantable cardiac devices prohibit its use, although this may gradually have less impact with the advent of MRI-safe technologies. MRI should also be avoided in patients with impaired kidney function (possibility of nephrogenic systemic fibrosis) and claustrophobia.24

Rotation angiography

Rotational angiography with 3D reconstruction is a recently introduced imaging modality that allows acquisition of volume images of cardiac chambers (or blood vessels) by rotating the X-ray C-arm around the area of interest while injecting contrast (Figure 3). It was successfully applied to LA imaging and was named 3D atriography (3DATG).25–28 More recently, other chambers of the heart have been imaged with similar techniques.29 Left atrial and detailed PV anatomy can be visualized in a vast majority of patients by using a variety of injection protocols.25,27 Additionally, the esophagus can be simultaneously visualized by administration of oral contrast.25 Resultant 3D images are comparable in quality to CT with significantly smaller radiation exposure and can be successfully used to guide AF ablation procedures as a single modality or in combination with electroanatomical mapping (EAM).22,27,28,30,31 A randomized comparison of 3DATG and CARTO-guided AF ablation procedures did not demonstrate excessive fluoroscopy dose or inferior ablation success with 3DATG. The recently introduced EP Navigator (Philips Healthcare, Best, The Netherlands) allows one to overlay the 3D image of the chamber of interest on live fluoroscopy and register it using anatomic landmarks or catheter placement.22 Registered LA volume then becomes an integral part of the fluoroscopy screen, thereby providing a sole guide for the ablation procedure (Figure 4). Alternatively, 3DATG can be imported into the CARTO system or NavX (Figure 5) and provide real-time anatomical information to supplement EAM.28


Figure 3: (a) The 3DRA Rotational Angiogram with 3D reconstruction and corresponding computed tomography (CT) image in the same patient. (a) Reconstructed 3DRA image; (b) still-frame image from a rotational angiogram; (c) CT reconstruction. Note a close concordance between a more realistic 3DRA and a CT image; fine detail and branching of pulmonary veins (PVs) (LUPV: left upper PV; LLPV: left lower PV) are easily seen on 3DRA, and esophageal (e) position is very similar between both methods.25 (b) Three-dimensional reconstruction of the left atrium and pulmonary veins in the same patient. (a) Rotational angiography during adenosine-induced asystole. (b) Automatic segmentation of the left atrium and pulmonary veins. (c) Three-dimensional reconstruction of left atrium and pulmonary veins. (d) Computed tomographic imaging of left atrium and pulmonary veins. LAA: left atrial appendage; LSPV: left superior pulmonary vein; RIPV: right inferior pulmonary vein; RSPV: right superior pulmonary vein.27



Figure 4: Three-dimensional atriography of the left atrium (LA) with ablation point tagging. Endoview of the LA is shown. Also seen are CS coronary sinus catheter and transseptal sheath with Lasso catheter.



Figure 5: (a) NavX (left image) and three-dimensional atriography (3DATG) (right image) in the same patient seen side by side. (b) Fusion of NavX and 3DATG images produces a truly electroanatomical map and allows visualization of live catheter position (shown are Lasso catheter in the right lower pulmonary vein, ablation catheter at the posterior LA wall and CS catheter).

Advantages of 3DATG include simplicity and familiarity with angiography for most operators, real-time anatomical information of CT-like quality with less cost and radiation exposure. These anatomical images can be used to guide the ablation procedure as a single tool or be easily integrated into the existing EAM. Imaging is performed in the laboratory and therefore reflects the volume status and position of surrounding structures (esophagus) more reliably than remote CT.25 The disadvantages are the need for contrast and some radiation exposure as well as a learning curve for the staff (unlike CARTO and NavX, no technical support during the procedure is currently offered by the imaging companies producing the equipment).

Transesophageal echocardiography/3D transesophageal echocardiography

Transesophageal echocardiography (TEE) is an important pre- and intraprocedural imaging tool for AF ablation. It is the method of choice to rule out the presence of LA appendage thrombus. It provides accurate anatomic information about the LA and PVs. Transesophageal echocardiography may be used to guide the transseptal puncture and ablation catheter navigation since it has been proven to be helpful in directly imaging the fossa ovalis, especially in subverted cardiac anatomies.32 Advantages of TEE include its wide availability, familiarity with the technique for most institutions, and absence of radiation exposure. However, use of 2D TEE alone to guide AF ablation may be impractical for a number of reasons. Three-dimensional TEE was recently introduced and has been mainly used to guide interventional valvular procedures (Figure 6).33 While it may be applicable to better evaluate 3D LA anatomy and possibly guide AF ablation procedure when merged with EAM, feasibility of this approach in humans remains to be evaluated.34


Figure 6: (a,b) Three-dimensional transesophageal echocardiography (3DTEE) and (c) intracardiac echocardiography image of the real-time 3DTEE during transseptal puncture and respective explicatory diagram showing angle (α) between the fossa ovalis and transseptal needle.33 (c) Top image: circular mapping catheter positioned at the ostium of the left upper pulmonary vein (LUPV). LAA indicates left atrial appendage. Bottom image: Right upper and right lower pulmonary veins (RUPV and RLPV) are visible. The circular mapping catheter (Lasso catheter) is placed in the RUPV.39

Intracardiac echocardiography/3D intracardiac echocardiography

Intracardiac echocardiography (ICE) is routinely used in many EP laboratories for intraprocedural imaging.35 Transseptal puncture can be made easier by ultrasound visualization of the fossa ovalis, especially during needle and sheath passage, an important consideration in difficult cases such as in patients with ASD(Atrial Septal Defect) repair where a synthetic patch may present an otherwise insurmountable obstacle.36 Intracardiac echocardiography provides excellent anatomical detail of the interatrial septum, PV antra, ridges, and other important parts of the LA, allowing one to fine tune the ablation catheter position in order to achieve antral PV isolation or target carinal areas (Figure 6). By providing the location of vital surrounding structures and their relationship to the LA, ICE may be used to avoid catastrophic complications such as atrioesophageal fistula.6,37 ICE has been also used to detect pericardial effusion, thrombus formation, and to titrate the RF energy delivery to avoid microbubble appearance or char formation.38,39 ICE technology is improving at a phenomenal pace. Innovations include better transducers with higher resolution and frequency agility (computer micromachined transducers: cMUTs), ultrasound probes incorporating a port for a radiofrequency wire allowing simultaneous visualization and ablation, percutaneous intrapericardial echocardiography, and 4D ICE with gated reconstruction of cardiac motion.40 Further advancements include ICE image integration with EAM, which will be discussed in a later section. The main advantages of ICE are no need for anesthesia and full control over imaging by an electrophysiologist. The challenges are a significant cost of a single use ICE probe and inability to obtain high-quality imaging in all patients.

Electroanatomical mapping

Electroanatomical methods have quickly gained momentum in the area of AF ablation. CARTO System, Biosense Webster, Diamond Bar, CA, USA and NavX (St Jude Medical, St. Paul, MN, USA) are two dominant modalities that provide similar electrogram and location data. Recently, a new non-fluoroscopic GPS-guided method—Mediguide (St. Jude Medical, St.Paul, MN, USA)—has been described.41 Electroanatomical mapping (EAM) provides activation data important in localization of macro-re-entrant and focal arrhythmias, local voltage information confirming successful ablation, and allowing characterization of its impact on overall LA function.42,43 Both encircling and linear lesions are easily assisted by EAM (Figure 7).44 The accuracy of electroanatomic 3D shells of the LA and the relationship to the esophagus was compared with CT data and was shown to be adequate for most locations. However, some discrepancies between the true and assumed anatomy (based on electromagnetic field measurements) exist and should be considered, particularly for robotic applications where the potential for cardiac perforation due to inaccurate location of the chamber wall may be higher because of the absence of tactile contact pressure information.45 The accuracy of EAM data confirming completeness of PV isolation (PVI) was compared with standard Lasso techniques and was found to be adequate.46 This may require a very detailed EAM and validation in larger studies before the well-established Lasso technique can be abandoned. EAM allows visualization of the ablation and Lasso catheter in real-time and thus the ablation procedure can be guided and lesion progress more easily tracked. Use of these methods clearly reduces fluoroscopy exposure to the staff and the patient; completely fluoroless ablation of AF using EAM as part of the imaging strategy was recently described.4,46,47


Figure 7: Left atrium maps (coronal view). (a and b) Preablation and postablation maps, respectively. Red spheres indicate sites at which RF energy was deployed. Note ablation line, encircling superior pulmonary veins (b). (c) Postablation remapping of left atrium.44

The main advantages of EAM include their fluoroless nature, the ability to visualize and track multiple catheters near real-time and the ability to combine anatomical and electrical information in a single 3D map. Disadvantages include the lack of real-time anatomic feedback, possible distortion of anatomy during the procedure due to electrical impedance changes, or alterations in reference catheter or patch position. Point-by-point mapping required by some EAMs may distort the true anatomy because of catheter pressure or absence of catheter contact. Additionally, EAM requires specialized catheters or patches with associated extra costs and are dependent on specially trained staff/industry support in many institutions.

Merge technologies

CT/cardiac MRI/3DATG fluoroscopy merge

The idea of overlaying a 3D anatomical shell of the heart chamber on live fluoroscopy and “attaching” it to radiographic landmarks (registration) is attractive and has been realized relatively early on in AF ablation experience.48 Both CT, MRI and 3DATG data can be segmented and registered to a live X-ray screen.19,22,27,49 Early experience confirmed high accuracy of catheter navigation within properly registered images.48 Subsequent development of commercially available software (EP Navigator-Philips Healthcare, Best, The Netherlands, DynaCT Cardiac-DynaCT (Siemens, Forchheim, Germany) and its clinical application confirmed that registration error is typically 1–2 mm (Figure 8).19,28,50 One has to realize that overlay accuracy will not be absolutely perfect given physiologic heart and lung movements. Different registration methods based on superimposition of clearly identifiable anatomical landmarks (such as thoracic spine, right heart border) have been described. The easiest and most accurate method seems to be the superimposition of the reconstructed and the radiographic bronchial carina.22 A randomized comparison with EAM demonstrated similar radiation exposure when using CT overlay on live fluoroscopy as the only imaging guide and a shorter procedural time.50 This is explainable by availability of pre-acquired CT reconstructed anatomy and no need for additional time-consuming EAM. Similar data were obtained when comparing 3DATG versus CARTO as a single imaging guide.19


Figure 8: Validation of computed tomography (CT) registration. Anterior-posterior fluoroscopic view with CT overlay. Decapolar (a) and quadripolar (b) catheters inserted into the coronary sinus. (a) Registration based on catheter manipulation confirmed by looping a catheter in the left atrium accurately matching the overlaid CT volume. (b) Ablation catheter placed into the right superior pulmonary vein. Contrast injection at the ostium of the left superior pulmonary vein shows a perfect alignment of both images.19

Overlay methods allow the operator to perform catheter navigation within the 3D anatomical shell without the need for a specialized non-fluoroscopic mapping system. Endocardial views may be helpful to define PV antral positions or ridges. Difficult or atypical PV anatomy can be easier understood, thus allowing it to be reached with a catheter. Additionally, ablation point tagging helps keeping track of the ablation process, essentially positioning overlay systems as a standalone imaging modality for those EP procedures that do not require sophisticated electrogram mapping (Figure 4). These overlay tools are relatively inexpensive as they do not require specialized mapping catheters or patches. Disadvantages of purely X-ray-based methods include radiation exposure that may not be negligible with non-gated CT. 3DATG is associated with considerably less exposure and has been successfully used as a sole imaging tool to guide AF ablation.22,30 Another disadvantage of CT or MRI-based system is the lag between the actual imaging and the procedure day, as mentioned previously.

CT, MRI, or 3DATG with electroanatomical mapping

Fusion of 3D anatomical data with EAM was the next logical step in imaging development. It can theoretically correct anatomical imperfections of EAM methods while providing almost real-time non-fluoroscopic intraprocedural navigation guidance. Early publications praised feasibility and high accuracy of CT/MR and EAM fusion.51–55 Minimal discrepancy (about 2 mm) between the CT shell and mapping points was reported both in animals model in humans.51,54 The largest discrepancy was reported for the right ventricle image integration. This may be explained by the highly trabeculated nature of this chamber.51 Anatomical images taken at end-expiration were noted to integrate better with EAM, indicative of respiratory variability and the need to better synchronize different imaging modalities. The inability to maintain a long breath-hold may decrease accuracy of fused images for some patients. Good correlation between left atrium size determined by EAM and CT/MR was reported.52 However, the same authors have noted a greater integration error in patients with larger LA volumes, raising concerns about registration accuracy with fusion methods and leading some groups to declare that merge techniques do not improve procedural safety/efficacy.53 A later study comparing Carto-Merge versus Carto-XP has also reported a similarly modest long-term success rate of ablation guided by either method both in patients with paroxysmal (54% sinus rhythm maintenance at 12 months) and persistent AF (43% sinus rhythm maintenance).56 Reduced radiation exposure was noted with Carto-Merge. The Italian Carto-Merge registry reported improved long-term outcome after AF ablation guided by image integration versus Carto and Lasso catheter.57 However, the shortest procedural times were noted with the simple Lasso-guided approach. Other authors have attempted to improve image registration accuracy by adding ICE to the equation.58–60 ICE-guided image integration further reduced radiation exposure compared with MRI, but has again called into question registration methods.60 A higher precision of registration was reported when only posterior LA wall points were used for image fusion.58,60 Thus, attempts to improve registration accuracy have utilized additional imaging methods, with a potential for error multiplication when several modalities are fused into a combined image. Feasibility of combining intraprocedural 3DATG reconstruction of LA and PV with Carto was also reported.28 We have recently started fusing 3DATG with EnSite Velocity™ Cardiac Mapping System (St. Jude Medical, Minneapolis, MN) obtaining a combined, truly electroanatomical map of the chamber of interest (Figure 5). The same potential advantages of 3DATG versus CT or MRI discussed above will probably apply when used in combination with EAM.

Accurate superimposition of these fused images is a complex issue. It requires sophisticated computer algorithms and sometimes imagination. Reconstructed 3D shells of the chamber of interest, obtained by different methods, may simply be different depending on acquisition time, volume status, respiratory movement, etc. The task of their fusion is further complicated by the need for real-time positional reference once a combined image is ready to be overlaid on live fluoroscopy.19,22 61 Different methods to achieve registration were mentioned earlier. A different approach would entail the use of ICE to improve spatial detail and image integration (CartoSound, BiosenseWebster, Diamond Bar, CA) (Figure 9). While this method could potentially provide higher accuracy in mapping, it certainly may add another dimension in complexity to the fusion process.62,63


Figure 9: Demonstration of CartoSound left atrium model interpolation, using SoundStar contours from all transducer locations combined (posterior-anterior view; appendage and pulmonary veins removed for clarity): Top: SoundStar contours; middle: interpolated model grown around SoundStar contours; bottom: interpolated model alone.62

Future directions in imaging for atrial fibrillation ablation

Current ablation technologies continue to evolve rapidly. This progress is primarily driven by imperfect outcomes with existing methods, long procedural times, and higher than desired complication rates. Some of the new directions include endoscopic laser balloon ablation, MRI, and real time-ultrasound lesion characterization.

Laser balloon ablation is a recently described technique. The compliant balloon catheter incorporates an optical fiber that generates 30° arcs of light projected onto regions of balloon and PV contact; this allows direct visualization of lesion formation. Laser energy (980 nm) is then delivered through the same optical fiber to ablate the target tissue in an overlapping manner to achieve circumferential ablation (Figure 10). In animal models, successful isolation was confirmed in 83–90% of targeted PVs after more than 1 month.64,65 In humans 65–83% of patients were free of AF more than 1 month after ablation, and about 60% at long-term follow-up.65-68 Possible complications with this new technique are similar to radiofrequency catheter ablation, and include right phrenic nerve injury, pericardial effusion, thrombus formation, and esophageal damage.


Figure 10: The visually guided laser balloon ablation catheter. (a) Schematic representation of the catheter. Within the central shaft are the 2F endoscope, lesion generator, and cooling conduits for circulating D2O (Deuterium monoxide). The radiopaque “L” marker is located 180° opposite to the partially obscured view location seen on endoscopic visualization. (b) The balloon catheter. The catheter also consists of a variable diameter and compliant balloon, and an atraumatic and flexible tip. (c) The adjustable aiming point is also shown in a view from the tip of the catheter. This aiming point can be manipulated in a circumferential and longitudinal manner to control the site of laser energy delivery.65

Another new technology that may increase the success rate with PVI is contact force assessment during catheter ablation. The EFFICAS I trial proved that higher contact force exerted by the ablation catheter results in fewer late gap occurrences after PVI.69 Following the same principle, the contact force time integral can be represented on a patient specific MRI shell after the procedure and potentially predict likely sites of PV reconnection secondary to inadequate lesion formation.70 MRI is an emerging useful technique for lesion characterization. Using real-time MRI in a swine model, gaps in lesion sets were identified that could be ablated acutely, leading to improved outcomes.71 In a similar setting, post-ablation-delayed and T2 enhancement MRI was able to predict arrhythmia recurrence in 15 patients with paroxysmal AF.72

Ablation lesion formation and lesion characterization can be achieved in vivo by incorporating the ultrasound transducer into the ablation catheter. Early results are promising, allowing one to differentiate transmural necrosis from hemorrhage. There was a better correlation between ultrasound lesion characteristics and the degree of necrosis when compared to changes in local electrogram amplitude (Figure 11).73


Figure 11: (a) Real-time visualization of lesion formation on ultrasound (US) for epicardial ablation of the right atrium with the ring catheter. The red line indicates the change in US tissue contrast upon energy delivery. The ablation was stopped after incidence of a tissue pop, which is indicated on the image. Corresponding pathology and histology showed a lesion that was partially transmural. (b) Real-time visualization of catheter slippage on US for epicardial ablation of the right ventricle with the big TPX catheter. The red lines indicate the change in US tissue contrast upon energy delivery, and slippage is indicated by the arrow. Tissue back wall is not visible on the US image. Two distinct lesions were visible at the tissue surface and pathology cross-section.74

Another new direction involves a novel computational imaging method to detect localized electrical rotors or repetitive focal impulses. This approach utilizes Hilbert transform analysis on signals obtained from a 64-pole basket catheter (Constellation, Boston Scientific Corp., Boston, MA). In the CONFIRM Conventional Ablation for Atrial Fibrillation with or without Focal Impulse and Rotor Modulation trial, enrolling 103 patients with paroxysmal and persistent AF, rotors or focal beats were detected in 98% of patients. An ablation strategy based on rotor visualization improved procedural outcome (Figure 12).74,75


Figure 12: Rotor in Human Atrial Fibrillation . Shown in different colors is a rotor in a human left atrium during AF according to Dr. S. Narayan et al.

Mediguide Technology (St. Jude Medical, St.Paul, MN, USA)—is a new imaging tool that utilizes magnetic targeting.41 It locates the catheter tip, which carries a miniaturized sensor and projects its precise position in real-time on a previously acquired fluoroscopy image. This is another tool that imparts less radiation to the patient. Application of this method in EP is under investigation.


Complex EP procedures of today may frequently turn even more complex without sophisticated imaging. These guiding modalities have evolved from basic 2D concepts to advanced 3D techniques that often involve fusion of several datasets and overlay of real-time information. The complexity of some of these methods can be overwhelming for the operator and may require the participation of specialized support staff. Accuracy of navigation is often compromised by a summation of errors inherent with each individual technique. A quest for more user-friendly and highly accurate imaging tools continues and will hopefully result in the return of the “Golden Fleece”.


  1. Jaïs P, Haïssaguerre M, Shah DC, et al. A focal source of atrial fibrillation treated by discrete radiofrequency ablation. Circulation 1997; 4; 95:572–576.
  2. Lickfett L, Schwab JO, Lewalter T. Advanced mapping techniques in atrial fibrillation. J Interv Card Electrophysiol 2008; 22:155–159.
  3. Tuzcu V. A nonfluoroscopic approach for electrophysiology and catheter ablation procedures using a three-dimensional navigation system. Pacing Clin Electrophysiol 2007; 30:519–525.
  4. Reddy VY, Morales G, Ahmed H, et al. Catheter ablation of atrial fibrillation without the use of fluoroscopy. Heart Rhythm 2010; 7:1644–1653.
  5. Marom EM, Herndon JE, Kim YH, McAdams HP. Variations in pulmonary venous drainage to the left atrium: implications for radiofrequency ablation. Radiology 2004; 230:824–9.
  6. Pappone C, Oral H, Santinelli V, et al. Atrio-esophageal fistula as a complication of percutaneous transcatheter ablation of atrial fibrillation. Circulation 2004; 109:2724–2726.
  7. Lacomis JM, Wigginton W, Fuhrman C, Schwartzman D, Armfield DR, KM. Multi-detector row CT of the left atrium and pulmonary veins before radio-frequency catheter ablation for atrial fibrillation. Radiographics 2003; 23 Spec No:S35–48; discussion S48–50.
  8. Stanford W, Breen JF. CT evaluation of left atrial pulmonary venous anatomy. Int J Cardiovasc Imaging 2005; 21:133–139.
  9. Niinuma H, George RT, Arbab-Zadeh A, Lima JA, Henrikson CA. Imaging of pulmonary veins during catheter ablation for atrial fibrillation: the role of multi-slice computed tomography. Europace 2008; 10(suppl 3):iii14–21.
  10. Schwartzman D, Lacomis J, Wigginton WG. Characterization of left atrium and distal pulmonary vein morphology using multidimensional computed tomography. J Am Coll Cardiol 2003; 41:1349–1357.
  11. Mansour M, Holmvang G, Sosnovik D, et al. Assessment of pulmonary vein anatomic variability by magnetic resonance imaging: implications for catheter ablation techniques for atrial fibrillation. J Cardiovasc Electrophysiol 2004; 15:387–393.
  12. Daccarett M, Badger TJ, Akoum N, et al. Association of left atrial fibrosis detected by delayed-enhancement magnetic resonance imaging and the risk of stroke in patients with atrial fibrillation. J Am Coll Cardiol 2011; 57:831–838.
  13. Akoum N, Daccarett M, McGann C, et al. Atrial fibrosis helps select the appropriate patient and strategy in catheter ablation of atrial fibrillation: a DE-MRI guided approach. J Cardiovasc Electrophysiol 2011; 22:16–22.
  14. Badger TJ, Daccarett M, Akoum NW, et al. Evaluation of left atrial lesions after initial and repeat atrial fibrillation ablation: lessons learned from delayed-enhancement MRI in repeat ablation procedures. Circ Arrhythm Electrophysiol 2010; 3:249–259.
  15. Vergara GR, Vijayakumar S, Kholmovski EG, et al. Real-time magnetic resonance imaging-guided radiofrequency atrial ablation and visualization of lesion formation at 3 Tesla. Heart Rhythm 2011; 8:295–303.
  16. Taclas JE, Nezafat R, Wylie JV, et al. Relationship between intended sites of RF ablation and post-procedural scar in AF patients, using late gadolinium enhancement cardiovascular magnetic resonance. Heart Rhythm 2010; 7:489–496.
  17. Ector J, De Buck S, Loeckx D, et al. Changes in left atrial anatomy due to respiration: impact on three-dimensional image integration during atrial fibrillation ablation. J Cardiovasc Electrophysiol 2008; 19:828–834.
  18. Sra J, Narayan G, Krum D, et al. Computed tomography-fluoroscopy image integration-guided catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol 2007; 18:409–414.
  19. Knecht S, Skali H, O'Neill MD, et al. Computed tomography-fluoroscopy overlay evaluation during catheter ablation of left atrial arrhythmia. Europace 2008; 10:931–938.
  20. Daoud EG, Hummel JD, Houmsse M, et al. Comparison of computed tomography imaging with intraprocedural contrast esophagram: implications for catheter ablation of atrial fibrillation. Heart Rhythm 2008; 5:975–980.
  21. Coles DR, Smail MA, Negus IS, et al. Comparison of radiation doses from multislice computed tomography coronary angiography and conventional diagnostic angiography. J Am Coll Cardiol 2006; 47:1840–1845.
  22. Li JH, Haim M, Movassaghi B, et al. Segmentation and registration of three-dimensional rotational angiogram on live fluoroscopy to guide atrial fibrillation ablation: a new online imaging tool. Heart Rhythm 2009; 6:231–237.
  23. Hirai N, Horiguchi J, Fujioka C, et al. Prospective versus retrospective ECG-gated 64-detector coronary CT angiography: assessment of image quality, stenosis, and radiation dose. Radiology 2008; 248:424–430.
  24. Francis JM, Pennell DJ. Treatment of claustrophobia for cardiovascular magnetic resonance: use and effectiveness of mild sedation. J Cardiovasc Magn Reson 2000; 2:139–141.
  25. Orlov MV, Hoffmeister P, Chaudhry GM, et al. Three-dimensional rotational angiography of the left atrium and esophagus. A virtual computed tomography scan in the electrophysiology lab? Heart Rhythm 2007; 4:37–43.
  26. Thiagalingam A, Manzke R, D'Avila A, et al. Intraprocedural volume imaging of the left atrium and pulmonary veins with rotational X-ray angiography: implications for catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol 2008; 19:293–300.
  27. Kriatselis C, Tang M, Nedios S, Roser M, Gerds-Li H, Fleck E. Intraprocedural reconstruction of the left atrium and pulmonary veins as a single navigation tool for ablation of atrial fibrillation: a feasibility, efficacy, and safety study. Heart Rhythm 2009; 6:733–741.
  28. Nölker G, Asbach S, Gutleben KJ, et al. Image-integration of intraprocedural rotational angiography-based 3D reconstructions of left atrium and pulmonary veins into electroanatomical mapping: accuracy of a novel modality in atrial fibrillation ablation. J Cardiovasc Electrophysiol 2010; 21:278–283.
  29. Orlov MV, Ansari MM, Akrivakis STet al. First experience with rotational angiography of the right ventricle to guide ventricular tachycardia ablation. Heart Rhythm 2011; 8:207–211.
  30. Kriatselis C, Nedios S, Akrivakis S, et al. Intraprocedural imaging of left atrium and pulmonary veins: a comparison study between rotational angiography and cardiac computed tomography. Pacing Clin Electrophysiol 2011; 34:315–322.
  31. Orlov M, Jais P, O'Neill Met al. First experience with Electronav: combining anatomy and electrograms for AF ablation. Heart Rhythm 2010:7(suppl) PO5-29:S328 [poster].
  32. Tucker KJ, Curtis AB, Murphy J, et al. Transesophageal echocardiographic guidance of transseptal left heart catheterization during radiofrequency ablation of left-sided accessory pathways in humans. Pacing Clin Electrophysiol 1996; 19:272–281.
  33. Chierchia GB, Capulzini L, de Asmundis C, et al. First experience with real-time three-dimensional transoesophageal echocardiography-guided transseptal in patients undergoing atrial fibrillation ablation. Europace 2008; 10:1325–1328.
  34. Pua EC, Idriss SF, Wolf PD, Smith SW. Real-time three-dimensional transesophageal echocardiography for guiding interventional electrophysiology: feasibility study. Ultrason Imaging 2007; 29:182–194.
  35. Daoud EG, Kalbfleisch SJ, Hummel JD. Intracardiac echocardiography to guide transseptal left heart catheterization for radiofrequency catheter ablation. J Cardiovasc Electrophysiol 1999; 10:358–363.
  36. Lakkireddy D, Rangisetty U, Prasad S, et al. Intracardiac echo-guided radiofrequency catheter ablation of atrial fibrillation in patients with atrial septal defect or patent foramen ovale repair: a feasibility, safety, and efficacy study. J Cardiovasc Electrophysiol 200; 19:1137–1142.
  37. Good E, Oral H, Lemola K, et al. Movement of the esophagus during left atrial catheter ablation for atrial fibrillation. J Am Coll Cardiol 2005; 46:2107–2110.
  38. Wazni OM, Rossillo A, Marrouche NF, et al. Embolic events and char formation during pulmonary vein isolation in patients with atrial fibrillation: impact of different anticoagulation regimens and importance of intracardiac echo imaging. J Cardiovasc Electrophysiol 2005; 16:576–581.
  39. Marrouche NF, Martin DO, Wazni O, et al. Phased-array intracardiac echocardiography monitoring during pulmonary vein isolation in patients with atrial fibrillation: impact on outcome and complications. Circulation 2003; 107:2710–2716.
  40. Hijazi ZM, Shivkumar K, Sahn DJ. Intracardiac echocardiography during interventional and electrophysiological cardiac catheterization. Circulation 2009; 119:587–596.
  41. Rolf S, John S, Gaspar T, et al. Catheter ablation of atrial fibrillation using a new non-fluoroscopic sensor-guided 3D navigation tool (MediGuide™ Technology). Heart Rhythm 2011; 8(suppl) AB 12–6:S28 [abstract].
  42. Gurevitz OT, Glikson M, Asirvatham S, et al. Use of advanced mapping systems to guide ablation in complex cases: experience with noncontact mapping and electroanatomic mapping systems. Pacing Clin Electrophysiol 2005; 28:316–323.
  43. Takahashi Y, O'Neill MD, Hocini M, et al. Effects of stepwise ablation of chronic atrial fibrillation on atrial electrical and mechanical properties. J Am Coll Cardiol 2007; 49:1306–1314.
  44. Pappone C, Oreto G, Lamberti F, et al. Catheter ablation of paroxysmal atrial fibrillation using a 3D mapping system. Circulation 1999; 100:1203–1208.
  45. Piorkowski C, Hindricks G, Schreiber D, et al. Electroanatomic reconstruction of the left atrium, pulmonary veins, and esophagus compared with the “true anatomy” on multislice computed tomography in patients undergoing catheter ablation of atrial fibrillation. Heart Rhythm 2006; 3:317–327.
  46. Augello G, Vicedomini G, Saviano M, et al. Pulmonary vein isolation after circumferential pulmonary vein ablation: comparison between Lasso and three-dimensional electroanatomical assessment of complete electrical disconnection. Heart Rhythm 2009, 6:1706–1713.
  47. Ferguson JD, Helms A, Mangrum JM, et al. Catheter ablation of atrial fibrillation without fluoroscopy using intracardiac echocardiography and electroanatomic mapping. Circ Arrhythm Electrophysiol 2009; 2:611–619.
  48. Sra J, Krum D, Malloy A, et al. Registration of three-dimensional left atrial computed tomographic images with projection images obtained using fluoroscopy. Circulation 2005; 112:3763–3768.
  49. Ector J, De Buck S, Adams J, et al. Cardiac three-dimensional magnetic resonance imaging and fluoroscopy merging: a new approach for electroanatomic mapping to assist catheter ablation. Circulation 2005; 112:3769–3776.
  50. Stevenhagen J, Van Der Voort PH, Dekker LR, Bullens RW, Van Den Bosch H, Meijer A. Three-dimensional CT overlay in comparison to CartoMerge for pulmonary vein antrum isolation. J Cardiovasc Electrophysiol2010; 21:634–639.
  51. Tops LF, Bax JJ, Zeppenfeld K, et al. Fusion of multislice computed tomography imaging with three-dimensional electroanatomic mapping to guide radiofrequency catheter ablation procedures. Heart Rhythm 2005; 2:1076–1081.
  52. Heist EK, Chevalier J, Holmvang G, et al. Factors affecting error in integration of electroanatomic mapping with CT and MR imaging during catheter ablation of atrial fibrillation. J Interv Card Electrophysiol 2006; 17:21–27.
  53. Kistler PM, Rajappan K, Jahngir M, et al. The impact of CT image integration into an electroanatomic mapping system on clinical outcomes of catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol 2006; 17:1093–1101.
  54. Dong J, Calkins H, Solomon SB, et al. Integrated electroanatomic mapping with three-dimensional computed tomographic images for real-time guided ablations. Circulation 2006; 113:186–194.
  55. Malchano ZJ, Neuzil P, Cury RC, et al. Integration of cardiac CT/MR imaging with three-dimensional electroanatomical mapping to guide catheter manipulation in the left atrium: implications for catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol 2006; 17:1221–1229
  56. Caponi D, Corleto A, Scaglione M, et al. Ablation of atrial fibrillation: does the addition of three-dimensional magnetic resonance imaging of the left atrium to electroanatomic mapping improve the clinical outcome?: a randomized comparison of Carto-Merge vs. Carto-XP three-dimensional mapping ablation in patients with paroxysmal and persistent atrial fibrillation. Europace 2010, 12:1098–1104.
  57. Bertaglia E, Bella PD, Tondo C, et al. Image integration increases efficacy of paroxysmal atrial fibrillation catheter ablation: results from the CartoMerge Italian Registry. Europace 2009; 11:1004–1010.
  58. Fahmy TS, Mlcochova H, Wazni OM, et al. Intracardiac echo guided image integration: optimizing strategies for registration. J Cardiovasc Electrophysiol 2007; 18:276–282.
  59. Rossillo A, Indiani S, Bonso A, Themistoclakis S, Corrado A, Raviele A. Novel ICE-guided registration strategy for integration of electroanatomical mapping with three-dimensional CT/MR images to guide catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol 2009; 20:374–378.
  60. Pratola C, Baldo E, Artale Pet al. Different image integration modalities to guide AF ablation: impact on procedural and fluoroscopy times. Pacing Clin Electrophysiol 2011; 34:422–430.
  61. Auricchio A, Sorgente A, Soubelet E, et al. Accuracy and usefulness of fusion imaging between three-dimensional coronary sinus and coronary veins computed tomographic images with projection images obtained using fluoroscopy. Europace 2009; 11:1483–1490.
  62. Schwartzman D, Zhong H. On the use of CartoSound for left atrial navigation. J Cardiovasc Electrophysiol 2010; 21:656–664.
  63. den Uijl DW, Tops LF, Tolosana JM, et al. Real-time integration of intracardiac echocardiography and multislice computed tomography to guide radiofrequency catheter ablation for atrial fibrillation. Heart Rhythm 2008; 5:1403–1410.
  64. Gerstenfeld EP, Michele J. Pulmonary vein isolation using a compliant endoscopic laser balloon ablation system in a swine model. J Interv Card Electrophysiol 2010; 29:1–9.
  65. Dukkipati SR, Neuzil P, Skoda J, et al. Visual balloon-guided point-by-point ablation: reliable, reproducible, and persistent pulmonary vein isolation. Circ Arrhythm Electrophysiol 2010; 3:266–273.
  66. Reddy VY, Dukkipati SR, Neuzil P, et al. Pulmonary vein isolation using the visually guided laser balloon: the first 200-patient multicenter clinical experience. Heart Rhythm 2011; 8(suppl) AB36-1:S80–811 [abstract].
  67. Schmidt B, Metzner A, Chun KR, et al. Feasibility of circumferential pulmonary vein isolation using a novel endoscopic ablation system. Circ Arrhythm Electrophysiol 2010; 3:481–488.
  68. Gerstenfeld EP. New technologies for catheter ablation of atrial fibrillation. Curr Treat Options Cardiovasc Med 2011; 13:393–401.
  69. Reddy VY, Neuzil P, Kautzner J, et al. Low catheter-tissue contact force results in late PV reconnection. Heart Rhythm 2011; 8(suppl) AB12-1:S26 [abstract].
  70. Karim R, Gao G, Harrison J, et al. Magnetic resonance imaging analysis of tissue – contact force following catheter ablation for paroxysmal atrial fibrillation. Heart Rhythm 2011; 8(suppl) AB15-1:S33 [abstract].
  71. Ranjan R, Kholmovski EG, Vijayakumar S, et al. Using real time MRI to identify gaps in ablation lesion sets and ablating them acutely. Heart Rhythm 2011; 8(suppl) AB15-4:S34 [abstract].
  72. Arujuna A, Karim R, Caulfield D, et al. Interstitial oedema, delayed enhancement and recurrences following catheter ablation in paroxysmal AF: How are they related? Heart Rhythm 2011; 8(supple) AB15-5:S34–35 [abstract].
  73. Wright M, Harks E, Deladi S, et al. Real-time lesion assessment using a novel combined ultrasound and radiofrequency ablation catheter. Heart Rhythm 2011; 8:304–312.
  74. Narayan SM, Sehra R, Briggs C, et al. Rapid acute termination of human atrial fibrillation by focal impulse and rotor modulation: early human experience. Heart Rhythm 2011; 8(suppl) AB02-4:S4 [abstract].
  75. Narayan S, Shivkumar K, Mittal S, et al. Conventional Ablation For Atrial Fibrillation With Or Without Focal Impulse And Rotor Modulation (the CONFIRM Trial). Heart Rhythm 2011; 8(suppl)PO2-104:S185 [poster]